Abstract：Objective: To investigate and analyze the geriatric medication information in the package inserts of cardiovascular drugs in the current domestic market in order to provide reference for standardization of the package inserts of cardiovascular drugs. Methods: All of the package inserts in domestic market were collected through MEDICOM software, and the package inserts of chemical cardiovascular drugs were screened out by reference to the Pharmacopoeia of China (2010), and the geriatric medication information were extracted and analyzed statistically. Result: Among 1 736 package inserts of chemical cardiovascular drugs, 1 549 (89.23%) included the item of “medication in elderly patients”, however, 5.76% of which stated “uncertain”. Besides, geriatric medication information was mentioned under the items of “dosage” (15.55%), “pharmacokinetics” (14.34%) and “precautions” (8.53%) in relatively high proportions, and in the lowest proportion under the items of “contraindications” (1.09%) and “overdose” (1.09%). What’s more, much of the geriatric medication information were meaningless. Conclusion: Geriatric medication information of clinical significance is insufficient in the package inserts of cardiovascular drugs, and the situation should be improved to e nsure the safety and efficacy of medication in elderly patients .
2017, Vol. 15 
